Navigating ESA Failure in MDS

Thomas LeBlanc. MD, MA, of Duke Cancer Institute, leads a discussion around strategies for managing patients with myelodysplastic syndromes in patients who experience ESA failure or are ineligible for ESA therapy. Leblanc is joined by Andrew Brunner, MD, of  Massachusetts General Hospital, and Jamie Koprivnikar, MD, of Hackensack University Medical Center.